

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
Tislelizumab imishonga yekurapa kenza inotarisa inobatsira immune system yako kurwisa mhando dzekenza dzakasiyana-siyana zvakanyanya. Imhando yemishonga ye immunotherapy inoshanda nekudzivisa protein inonzi PD-1, iyo maseru ekenza dzimwe nguva anoshandisa kuvanza kubva kudziviriro yechisikigo yemuviri wako.
Mishonga iyi inopiwa kuburikidza ne IV infusion kuchipatara kana nzvimbo yekurapa kenza. Chikwata chako chehutano chichakutarisa zvakanyatso panguva yekurapa kuti uve nechokwadi chekuti uri kupindura zvakanaka uye uchibata chero migumisiro yemativi inogona kuitika.
Tislelizumab ndeyemukirasi wemishonga inonzi PD-1 inhibitors kana checkpoint inhibitors. Funga nezvazvo sekubvisa "mabhureki" anodzivirira immune system yako kubva pakurwisa maseru ekenza zvakanyanya.
Mishonga iyi imonoclonal antibody, zvinoreva kuti iprotein yakagadzirwa murabhoritari yakagadzirirwa kutarisisa maseru chaiwo mumuviri wako. Inozivikanwawo nezita rekuti Tevimbra mune dzimwe nzvimbo, kunyangwe kuwanikwa kuchisiyana nenyika.
Kurapa uku kunomiririra nzira itsva yekuchengetedza kenza inoshandisa immune system yako pachayo panzvimbo yekurwisa zvakananga maseru ekenza sezvinoita chemotherapy yechinyakare.
Tislelizumab inonyanya kushandiswa kurapa mhando dzekenza dzakasiyana-siyana dzepamberi kana metastatic. Oncologist wako achasarudza kana mushonga uyu wakakodzera mamiriro ako chaiwo zvichibva pazvinhu zvakawanda.
Mishonga iyi inowanzo rongerwa kenza yepulmonary isiri diki-seli, kunyanya kana dzimwe nzira dzekurapa dzisina kubudirira kana kenza yapararira kune dzimwe nhengo dzemuviri. Inogonawo kushandiswa kune mamwe marudzi ekenza ye esophageal uye mamwe matumors akasimba.
Chiremba wako anogona kuyedza tumor yako kune mamwe ma biomarkers asati akurudzira kurapwa uku. Miedzo iyi inobatsira kuona kana tislelizumab ichikwanisa kushanda kune yako chaiyo mhando yekenza.
Mune dzimwe nguva, tislelizumab inogona kushandiswa pamwe chete nemamwe marapirwo ekenza senge chemotherapy kana radiation therapy kuti ivandudze kushanda kwese.
Tislelizumab inoshanda nekudzivisa nzira yePD-1, iyo maseru ekenza anowanzo shandisa kudzivirira kuonekwa nehutachiona hwako. Izvi zvinoonekwa semushonga we immunotherapy une simba zvine mwero unogona kuburitsa mhinduro dzakakosha mune vamwe varwere.
Kana maseru ekenza akabatana nePD-1 receptors pamaseru ekudzivirira, ivo vanotumira chiratidzo che
Unofanira kuronga kuti uve nemunhu anokutyaira kuenda nekudzoka kubva kumisangano yako yekurapa, kunyanya panguva yekutanga infusions yako, sezvo unogona kunzwa kuneta kana zvimwe zvinokonzeresa.
Kureba kwekurapa kwe tislelizumab kunosiyana zvakanyanya kubva kumunhu nemunhu uye kunoenderana nekuti kenza yako inopindura sei kumushonga. Varwere vazhinji vanogamuchira infusions mumasvondo matatu kusvika mana ega ega.
Oncologist wako achatarisa nguva dzose kufambira mberi kwako kuburikidza nekutarisa mifananidzo, bvunzo dzeropa, uye kuongororwa kwemuviri kuti aone kana kurapwa kuri kushanda nemazvo. Ongororo idzi dzinowanzoitika mumasvondo matanhatu kusvika gumi nemaviri ega ega.
Vamwe varwere vanogona kuramba vachirapwa kwemwedzi yakawanda kana kunyange makore kana vachipindura zvakanaka uye vachishivirira mushonga pasina mhedzisiro yakakomba. Vamwe vangangoda kumira nekukurumidza kana kenza ikafambira mberi kana kana mhedzisiro yave yakaoma kwazvo kubata.
Sarudzo yekuramba kana kumisa kurapwa ichagadzirwa nguva dzose pamwe chete pakati pako nechikwata chako chehutano, tichifunga nezvehutano hwako hwese, hupenyu hwemhando yepamusoro, uye zvinangwa zvekurapa.
Kufanana nekurapa kwese kenza, tislelizumab inogona kukonzera mhedzisiro, kunyangwe kwete munhu wese anozviona. Mhedzisiro inoitika nekuti mushonga unovhura immune system yako, iyo dzimwe nguva inogona kukanganisa matishu ane hutano pamwe chete nemaseru ekenza.
Kunzwisisa zvekutarisira kunogona kukubatsira kuti unzwe wakagadzirira uye uzive kuti ungabatana riini nechikwata chako chehutano kuti uwane rutsigiro.
Mhedzisiro inonyanya kuzivikanwa inowanzoita kuti ibatwe nekuchengetwa kwakakodzera kwekurapa uye inowanzoita kuti ivandudze sezvo muviri wako uchigadzirisa kurapwa.
Zvizhinji zvezvipingamupinyi izvi zviri nyore kusvika pakati nepakati uye zvinogona kubatwa zvakanaka nekutsigira matanho ekuchengetedza uye mishonga kana zvichidikanwa.
Nepo zvisingawanzoitiki, vamwe varwere vanogona kusangana nezviratidzo zvakakomba zvinoda kutariswa kwekurapa nekukasira. Izvi zvinowanika kana immune system ichiita zvakanyanya uye inorwisa nhengo dzine hutano.
Chikwata chako chehutano chichakutarisa zvakanyanya kuti uone matambudziko aya kuburikidza nekuongororwa kweropa nguva dzose uye kuongororwa panguva yekurapa kwako.
Muzviitiko zvisingawanzoitiki, tislelizumab inogona kukonzera matambudziko akakomba ane chekuita neimmune anokanganisa akawanda nhengo dzemuviri panguva imwe chete. Izvi zvinoda kupinda muchipatara nekukasira uye kurapwa kwakanyanya.
Nepo matambudziko aya asiri akajairika, chikwata chako chekurapa chakagadzirira zvakanaka kuziva nekukurumidza kana zvichiitika.
Mamwe mamiriro ezvinhu ezvokurapa uye mamiriro anogona kuita kuti tislelizumab isakakodzera kana kuda matanho akakosha. Chiremba wako weoncologist achanyatsoongorora nhoroondo yako yezvokurapa asati akurudzira kurapwa uku.
Vanhu vane zvirwere zve autoimmune zvinoshanda vangave vasiri vakakodzera mushonga uyu, sezvo ungawedzera mamiriro avo aripo nekukurudzira zvakanyanya immune system.
Kana uine nhoroondo yezvinetso zvakanyanya zve allergic kumishonga yakafanana kana chero zvikamu zve tislelizumab, chiremba wako anogona kukurudzira dzimwe nzira dzekurapa.
Varwere vane zvirwere zvinoshanda, kunyanya zvirwere zvakakomba zvebhakitiriya, hutachiona, kana fungal, vangangoda kumirira kusvikira izvi zvagadziriswa vasati vatanga kurapwa.
Vakadzi vane pamuviri kana kuyamwisa havafaniri kugamuchira tislelizumab, sezvo ingakuvadza mwana ari kukura. Kudzivirira pamuviri kunoshanda kwakakosha panguva yekurapwa uye kwemwedzi yakati wandei mushure meizvozvo.
Vanhu vane mamwe marudzi ekuchinjiswa kwenhengo vangave vasiri vakakodzera, sezvo mushonga ungawedzera njodzi yekurambwa kwenhengo.
Tislelizumab inotengeswa pasi pemazita akasiyana-siyana zvichienderana nenzvimbo yako yenzvimbo. Zita rinowanzozivikanwa ndere Tevimbra, kunyangwe kuwanikwa kuchisiyana nenyika uye mvumo yekutonga.
Mune dzimwe nzvimbo, unogona kuiona ichinzi zita rayo re generic, tislelizumab, kana nekugadzirwa kwekutsvaga senge BGB-A317. Pharmacy yako nechikwata chehutano zvichaziva zita rakatarwa rinoshandiswa munzvimbo yako.
Mushonga uyu wakafanana zvisinei nezita remhando, saka unogona kunzwa uine chivimbo chekuti uri kugamuchira kurapwa kumwe chete kwakadzidzwa mumiedzo yekiriniki.
Mamwe maPD-1 inhibitors anowanikwa anoshanda zvakafanana ne tislelizumab. Chiremba wako weoncologist angangofunga nezveimwe nzira idzi zvichienderana nerudzi rwako rwegomarara, nhoroondo yezvokurapa, uye inishuwarenzi.
Pembrolizumab (Keytruda) ndechimwe chezvimwe zvinoshandiswa zvakanyanya uye chine mvumo yemhando dzakawanda dzekenza dzakafanana. Nivolumab (Opdivo) ndechimwe chimwe chinhu chakasimbiswa zvakanyanya uye chinoshandiswa mukiriniki.
Zvimwe zvinodzivirira checkpoint zvakaita se durvalumab (Imfinzi) uye atezolizumab (Tecentriq) zvinotarisa nzira yakasiyana zvishoma asi dzimwe nguva zvinogona kushandiswa sezvimwe zvinhu zvichienderana nemamiriro ako ezvinhu.
Chiremba wako achakubatsira kunzwisisa kuti ndeipi sarudzo ingave yakanakira mamiriro ako chaiwo, achifunga nezvezvinhu zvakaita sekushanda, maitiro ekugadzirisa, uye zvekushandisa.
Zvese tislelizumab uye pembrolizumab zvinoshanda PD-1 inhibitors, asi kuona kuti ndeipi iri
Tislelizumab kazhinji haikurudzirwi vanhu vane zvirwere zve autoimmune zviri kushanda nekuti zvinogona kuita kuti mamiriro acho aipisise. Mushonga unoshanda nekukurudzira immune system yako, iyo inogona kuwedzera zvirwere zve autoimmune zvakadai se rheumatoid arthritis, lupus, kana inflammatory bowel disease.
Zvisinei, kana uine nhoroondo yezvirwere zvishoma zve autoimmune zviri kudzora zvakanaka, oncologist wako angangofunga kurapa uku mune mamwe mamiriro. Vachayerera mabhenefiti anogona kuitika vachipesana nenjodzi uye vachakutarisa zvakanyanya kana kurapwa kuchienderera mberi.
Sezvo tislelizumab ichipiwa panzvimbo yekurapa, hauzokanganwi dose kumba. Zvisinei, kana uchida kuronga zvakare musangano wako, taura nechikwata chako chehutano nekukurumidza sezvinobvira kuti uronge nguva itsva.
Zvakakosha kuchengetedza chirongwa chako chekurapa pedyo sezvinobvira kuti uwane mhedzisiro yakanaka. Chikwata chako chekurapa chichashanda newe kuti uwane imwe nguva yakakodzera yemusangano kana kusangana kwekuronga kukamuka.
Kana iwe ukawana mhedzisiro yakaipa yakanyanya senge kuoma kufema, manyoka akanyanya, kuneta kukuru, kana chero zviratidzo zvinonetsa, taura nechikwata chako chehutano nekukurumidza. Nzvimbo zhinji dzekenza dzine hotlines dzemaawa makumi maviri nemana dzevarwere vari kurapwa.
Usamirira kuti uone kana zviratidzo zvichivandudza zvega, kunyanya kana zvichikanganisa kugona kwako kudya, kunwa, kana kushanda zvakajairika. Kupindira kwekutanga kazhinji kunogona kudzivirira matambudziko akakomba kubva mukuvandudza.
Sarudzo yekumisa kurapwa kwe tislelizumab ichagadzirwa nguva dzose pamwe chete ne oncologist wako zvichibva pazvinhu zvakati wandei zvinosanganisira kuti kenza yako iri kupindura sei, chero mhedzisiro yawakawana, uye hutano hwako hwese.
Vamwe varwere vangamira kurapwa kana kenza yavo ikafambira mberi pasinei nemushonga, asi vamwe vangarega nekuda kwemigumisiro. Mune dzimwe nguva, varwere vangatora zororo rekurapwa vozotangazve gare gare kana mamiriro ezvinhu achichinja.
Majekiseni mhenyu anofanira kudziviswa paunenge uchitora kurapwa kwe tislelizumab, nekuti anogona kukonzera zvirwere zvakakomba muvanhu vane masisitimu ekudzivirira muviri akachinjwa. Zvisinei, majekiseni asina basa semjekiseni wefuruu anowanzo chengeteka uye anowanzo kurudzirwa.
Gara uchikurukura chero majekiseni akarongwa nechikwata chako chehutano usati aawana. Vanogona kukupa zano panguva uye kuti ndeapi majekiseni akachengeteka panguva yekurapwa kwako.
Get clear medical guidance
on symptoms, medications, and lab reports.
Download August today. No appointments. Just answers you can trust.